Published in Eur Heart J on October 27, 2011
Treatment for chronic heart failure in the elderly: current practice and problems. Heart Fail Rev (2013) 0.93
Venous thromboembolism in Croatia - Croatian Cooperative Group for Hematologic Diseases (CROHEM) study. Croat Med J (2015) 0.75
Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research Study. PLoS One (2016) 0.75
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet (1999) 8.44
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med (1991) 7.62
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12
Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77
Massive pulmonary embolism. Circulation (2006) 2.27
Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med (2010) 2.11
Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation (2004) 2.05
Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. Chest (2007) 1.38
Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost (2009) 1.09
Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost (2008) 0.99
Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE). Haematologica (2006) 0.99
Length of hospital stay for treatment of deep venous thrombosis and the incidence of recurrent thromboembolism. Arch Intern Med (1998) 0.94
Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation. Vasc Health Risk Manag (2008) 0.89
Age, outcomes, and treatment effects of fibrinolytic and antithrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT)-3 and ASSENT-3 PLUS. Am Heart J (2006) 0.83
Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials). J Thromb Thrombolysis (2006) 0.83
Outpatient management of acute deep vein thrombosis: results from the OTIS-DVT registry. Thromb Res (2011) 0.80
Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J (2006) 17.53
Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med (2014) 9.33
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J (2014) 6.32
The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord (2008) 5.33
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet (2011) 2.88
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. Circulation (2013) 2.64
Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice? J Am Coll Cardiol (2003) 2.59
Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. Am J Med (2004) 2.22
Right ventricular enlargement on chest computed tomography: prognostic role in acute pulmonary embolism. Circulation (2004) 2.21
Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv (2011) 2.18
Are circulating endothelial-derived and platelet-derived microparticles a pathogenic factor in the cisplatin-induced stroke? Stroke (2007) 2.17
Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther (2008) 2.13
The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage. Arch Intern Med (2004) 2.11
Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation (2013) 2.08
Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation (2004) 2.05
Infrapopliteal lesion morphology in patients with critical limb ischemia: implications for the development of anti-restenosis technologies. J Endovasc Ther (2013) 2.04
The vasodilatory response of skin microcirculation to local heating is subject to desensitization. Microcirculation (2009) 2.02
Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation (2004) 1.97
Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation (2002) 1.94
Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. Circulation (2004) 1.90
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J (2013) 1.90
Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE-/- mice. Hypertension (2004) 1.89
Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. JAMA (2005) 1.82
Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke (2006) 1.71
Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population. J Hypertens (2002) 1.64
A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. J Am Coll Cardiol (2012) 1.64
Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One (2009) 1.56
Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol (2010) 1.55
Endovascular treatment of Angio-Seal-related limb ischemia--primary results and long-term follow-up. Catheter Cardiovasc Interv (2010) 1.54
Aortic neck dilatation after endovascular abdominal aortic aneurysm repair: a word of caution. J Vasc Surg (2008) 1.53
Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. Eur Heart J (2010) 1.51
Catheter-directed ultrasound-accelerated thrombolysis for the treatment of acute pulmonary embolism. Thromb Res (2011) 1.51
Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial. Circulation (2013) 1.49
TASC II section F on revascularization: commentary from an interventionist's point of view. J Endovasc Ther (2007) 1.49
Confounding effects of heart rate on pulse wave velocity in paced patients with a low degree of atherosclerosis. J Hypertens (2004) 1.47
Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins. Dermatol Surg (2004) 1.45
Starting a carotid artery stenting program is safe. Catheter Cardiovasc Interv (2008) 1.44
Bleeding complications after systematic switch of routine thromboprophylaxis for major orthopaedic surgery. Thromb Haemost (2008) 1.41
Single-center experience in endovascular treatment for infrainguinal bypass obstructions. J Vasc Interv Radiol (2012) 1.40
Bailout revascularization of chronic femoral artery occlusions with the new outback catheter following failed conventional endovascular intervention. J Endovasc Ther (2009) 1.39
Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol (2005) 1.34
High prevalence of peripheral arterial disease in HIV-infected persons. Clin Infect Dis (2008) 1.34
Low-pressure environment and remodelling of the forearm vein in Brescia-Cimino haemodialysis access. Nephrol Dial Transplant (2002) 1.29
Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis (2010) 1.27
Prevalence, awareness, treatment and control of high blood pressure in a Swiss city general population: the CoLaus study. Eur J Cardiovasc Prev Rehabil (2009) 1.22
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis (2008) 1.16
Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis. J Hepatol (2005) 1.13
Warfarin dosing and cytochrome P450 2C9 polymorphisms. Thromb Haemost (2004) 1.12
Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption. Am J Cardiol (2008) 1.12
Non-coronary atherosclerosis. Eur Heart J (2014) 1.11
Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects. Intensive Care Med (2007) 1.10
Revascularization for chronic critical lower limb ischemia in octogenarians is worthwhile. J Vasc Surg (2007) 1.09
Contrast-enhanced ultrasound for assessing carotid atherosclerotic plaque lesions. AJR Am J Roentgenol (2012) 1.09
Impact of obesity on venous hemodynamics of the lower limbs. J Vasc Surg (2010) 1.08
Catheter-based reperfusion treatment of pulmonary embolism. Circulation (2011) 1.07
The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008. Prev Chronic Dis (2011) 1.07
Medication errors associated with anticoagulant therapy in the hospital. Am J Cardiol (2004) 1.05
Triple rule-out CT in patients with suspicion of acute pulmonary embolism: findings and accuracy. Acad Radiol (2009) 1.04
Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease. Acta Paediatr Suppl (2006) 1.04
Major bleeding complications in a specialized anticoagulation service. Am J Cardiol (2005) 1.03
Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism. J Gen Intern Med (2014) 1.02
Fatal pericardial tamponade after Wallstent implantation for malignant superior vena cava syndrome. J Endovasc Ther (2002) 1.02
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Hypertension (2008) 1.02
Diabetic neuropathy is a more important determinant of baroreflex sensitivity than carotid elasticity in type 2 diabetes. Hypertension (2005) 1.01
Microcirculation abnormalities in patients with fibromyalgia - measured by capillary microscopy and laser fluxmetry. Arthritis Res Ther (2004) 1.00
Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol (2006) 1.00
Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in postoperative patients. Thromb Haemost (2005) 0.99
Images in clinical medicine. Work-related vascular injuries of the hand--hypothenar hammer syndrome. N Engl J Med (2002) 0.97
Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg (2007) 0.96
Endothelial progenitor cells induce a phenotype shift in differentiated endothelial cells towards PDGF/PDGFRβ axis-mediated angiogenesis. PLoS One (2010) 0.95
Chronic mesenteric ischemia: critical review and guidelines for management. Ann Vasc Surg (2012) 0.95
Vascular risk factors in the Swiss population. J Neurol (2005) 0.95
Invasive aspergillosis in non-neutropenic patients. Eur J Intern Med (2009) 0.95
Cap G, a gelsolin family protein modulating protective effects of unidirectional shear stress. J Biol Chem (2003) 0.94
Gender is an independent risk factor for distribution pattern and lesion morphology in chronic critical limb ischemia. J Vasc Surg (2011) 0.94
Novel insight into the pathobiology of abdominal aortic aneurysm and potential future treatment concepts. Prog Cardiovasc Dis (2007) 0.93
Early recoil after balloon angioplasty of tibial artery obstructions in patients with critical limb ischemia. J Endovasc Ther (2014) 0.92
Oxidized low density lipoprotein impairs endothelial progenitor cell function by downregulation of E-selectin and integrin alpha(v)beta5. Biochem Biophys Res Commun (2008) 0.92
A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J (2007) 0.91
Falsely high ankle-brachial index predicts major amputation in critical limb ischemia. Vasc Med (2006) 0.91
Sustained remission 11 years after percutaneous ultrasound-guided aspiration for cystic adventitial degeneration in the popliteal artery. J Endovasc Ther (2007) 0.91
Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland. Eur J Cardiovasc Prev Rehabil (2008) 0.91
Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis. Arthritis Care Res (Hoboken) (2012) 0.91
Small, dense LDL particles predict changes in intima media thickness and insulin resistance in men with type 2 diabetes and prediabetes--a prospective cohort study. PLoS One (2013) 0.91
Ultrasound-assisted thrombolysis for acute pulmonary embolism: a systematic review. Eur Heart J (2014) 0.91
Sustained impact of electronic alerts on rate of prophylaxis against venous thromboembolism. Thromb Haemost (2011) 0.91
Characterization of human late outgrowth endothelial progenitor-derived cells under various flow conditions. J Vasc Res (2011) 0.90
The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology. J Thromb Thrombolysis (2013) 0.90
Novel applications of contrast-enhanced ultrasound imaging in vascular medicine. Vasa (2013) 0.90